Yang, Jingyan http://orcid.org/0000-0001-5523-649X
Blinzler, Kelly
Lankin, Joshua
Vijayakumar, Sapna
Maculaitis, Martine C.
Shelbaya, Ahmed
Funding for this research was provided by:
Pfizer
Article History
Accepted: 2 November 2021
First Online: 25 November 2021
Declarations
:
: This study was sponsored by Pfizer Inc. The sponsor’s role in study design, collection, analysis, and interpretation of data; writing of the manuscript; and the decision to submit the manuscript for publication was limited to the involvement of two of the manuscript authors who are employees of the sponsor.
: Dr. Yang and Dr. Shelbaya are employees of and hold stock in Pfizer Inc. Ms. Blinzler, Mr. Lankin, Dr. Vijayakumar, and Dr. Maculaitis are employees of Kantar Health, which received funding from Pfizer for conducting and reporting on the study.
: The current study utilized deidentified qualitative interview data. The study protocol was reviewed and deemed exempt by Pearl Institutional Review Board (protocol: 20-KANT-236) according to FDA 21 CFR 56.104 and 45CFR46.104(b)(2). The study was conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: To be eligible to participate in this study, respondents had to provide informed consent, which was collected from each respondent electronically.
: The informed consent statement indicated that data collected from respondents would be reported along with the data of other participants and advised respondents that they could not be personally identified with their responses. Thus, when providing their consent to participate in the study, respondents likewise consented to the publication of the study data.
: Data and study materials can be made available for non-commercial use upon reasonable request to the corresponding author.
: Codes can be made available for non-commercial use upon reasonable request to the corresponding author.
: Jingyan Yang: Conceptualization, methodology, writing of the original draft, and revisions. Joshua Lankin: Methodology, interview, modeling, and manuscript review and revisions. Kelly Blinzler: Conceptualization, methodology, interview, supervision, and manuscript review and revisions. Sapna Vijayakumar: Modeling and manuscript review and revisions. Martine C. Maculaitis: Supervision and manuscript review and revisions. Ahmed Shelbaya: Conceptualization, supervision, and manuscript review and revisions. All authors approved of the final version of the manuscript to be published and agreed to be accountable for all aspects of the work.
: A portion of the results reported in this manuscript was presented at the virtual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual conference, 17–20 May 2021.